Introduction
============

While we are still uncovering the survival strategies used by *M. tuberculosis* within a host, it is clear that these strategies are very effective: approximately one-third of the world\'s population is infected with tuberculosis (Corbett et al., [@B13]). Infection progresses to active tuberculosis, characterized by coughing and weakness, in approximately 5--10% of cases. Without proper, long-term treatment, tuberculosis can be fatal. Currently, the death rate from tuberculosis is approximately 1.7 million deaths per year, the highest for any single bacterial pathogen (Glaziou et al., [@B22]). Infected individuals who do not progress to active tuberculosis are said to develop latent tuberculosis, and represent a potential reservoir for future infection. Bacteria within latently infected individuals are often localized to granulomas, which are dense areas of both live and dead immune cells where the bacteria survive at a low but persistent level. Since the initial sequencing of *M. tuberculosis* in 1998 (Cole et al., [@B11]), many expression studies have been published in an attempt to better understand the survival mechanisms of this deadly pathogen (Kendall et al., [@B30]; Waddell et al., [@B63]; Haller et al., [@B24]). In a post-genomic era, we now need to learn how to utilize these expression data to better understand the ever-growing problem of tuberculosis.

*Mycobacterium tuberculosis* is an intracellular pathogen that infects via aerosolization from an infected host. After inhalation by a naïve host, the bacteria localize to the alveoli of the lungs, where they are phagocytosed by alveolar macrophages. *M. tuberculosis* is able to reside and even replicate within the normally toxic phagosomal compartment of human macrophages by using a variety of strategies, including the prevention of phagosome:lysosome fusion (Chua et al., [@B10]), prevention of phagosome acidification (Sturgill-Koszycki et al., [@B56]), and detoxification of the stresses it encounters in this environment (Hingley-Wilson et al., [@B28]; Hestvik et al., [@B27]; Warner and Mizrahi, [@B67]). One detriment to tuberculosis research is the difficulty of working with the pathogenic *M. tuberculosis* bacteria. The severity of the disease combined with the extremely low infectious dose (1--10 bacteria) means that research must be conducted within specialized facilities. Further, the lengthy doubling time (approximately 1 day) makes work progress slowly while the unique, fatty-aid rich cell wall makes the extraction of well-preserved RNA difficult. As such, most of the expression studies conducted with *M. tuberculosis* have taken place *in vitro* and not within a living host. Until recently, *in vivo* analysis on a genome-wide level was not even possible.

Fortunately, many *in vitro* models have been developed that attempt to replicate aspects of the *in vivo* environment using large-scale analysis approaches, including low oxygen levels (Rustad et al., [@B47]), low nutrients (Betts et al., [@B5]), and the addition of exogenous stresses (Stewart et al., [@B55]; Deb et al., [@B16]). While these models have been very useful in identifying and characterizing genes within *M. tuberculosis*, they are limited in their ability to identify survival strategies specific to the *M. tuberculosis in vivo* lifestyle. Our review will briefly discuss those *in vitro* models that improved our understanding of tuberculosis pathogenesis. However, this review focuses specifically on large-scale expression profiling experiments that have been conducted *in vivo* within host systems of tuberculosis. In particular, we emphasize instances where *in vivo* expression profiling has led to the discovery of genes that have been confirmed experimentally to be required for full virulence and/or survival of *M. tuberculosis*. These discoveries suggest that *in vivo* expression profiling is a valid strategy to identify transcripts directly relevant to the development of tuberculosis.

Major Approaches for Transcriptional Profiling of *M. Tuberculosis*
===================================================================

Transcriptional profiling can be performed in several different ways. One of the simplest and most commonly used methods to determine transcript levels within bacteria such as *M. tuberculosis* is RT-PCR. Because gene-specific primers are required for the amplification and quantification of transcripts, this technique is used for studies of specific genes that are of particular interest to the researcher. Because it measures transcript levels of only a small number of specific, pre-chosen genes, RT-PCR is not generally useful at identifying novel pathways or new targets for research. However, RT-PCR remains a popular and pragmatic technique for measuring gene expression, particularly during *in vivo* infection (Mariani et al., [@B35]; Timm et al., [@B62]; Shi et al., [@B51]; Srivastava et al., [@B54]; Kesavan et al., [@B31]). It is lower-cost than other profiling techniques, and it provides quantization levels that are generally considered to be more accurate than those provided by microarray analyses. It requires less bacterial RNA than other techniques, making it desirable in situations where only small amounts of RNA can be recovered, as is frequently the case in *M. tuberculosis* *in vivo* infections. Because it is more accurate than whole-genome techniques, RT-PCR is used as a confirmatory step in almost all microarray studies.

On the other hand, whole-genome microarray analyses provide transcriptional profiling without bias toward previously known genes. In this way, microarrays are able to identify interesting transcriptional changes in genes that may not have been previously characterized or studied, as well as large-scale trends occurring on a genome-wide level. Microarrays have frequently been used for the study of *in vitro* models of tuberculosis infection, but have been used less frequently to study *in vivo* models due to the difficulties in obtaining sufficient levels of mycobacterial RNA. Amplification techniques, although not yet widely utilized outside of human clinical samples, can alleviate this limitation in some situations (Waddell et al., [@B63]). Additionally, mycobacterial genome-directed primers (GDPs) have been developed to ensure that full-genome priming occurs in the presence of contaminating host transcripts (Talaat et al., [@B59]).

Recently, a novel sequencing-based approach for all RNA transcripts, RNA-Seq, has emerged as an alternative to microarrays for whole-genome transcriptional profiling (Wang et al., [@B65]). Although RNA-Seq is significantly more expensive than microarray technology, and requires large amounts of high-quality extracted RNA, it also presents many advantages relative to older techniques. The quantization provided by RNA-Seq is significantly more accurate than microarray analysis (Fu et al., [@B20]). Additionally, RNA-Seq provides the actual transcript sequences simultaneously with quantization data, rather than relying on predicted open reading frames in a given genome. This allows for the identification of other types of RNA (e.g., sRNAs or non-coding RNAs). RNA-Seq may be able to provide particularly interesting data for host-pathogen infection models, as it is theoretically capable of profiling both the host and the pathogen simultaneously. Although RNA-Seq has yet to be used to study *M. tuberculosis*, other bacterial pathogens have been successfully profiled using this new technology (Cossart and Archambaud, [@B14]; Albrecht et al., [@B2]; Sharma et al., [@B50]). Applying RNA-Seq to tuberculosis is an area of active research in our laboratory and others. In an attempt to establish a protocol for RNA-Seq in our hands, we have used RNA-Seq to analyze the transcriptomes of *M. tuberculosis* cultures grown *in vitro* to mid-log phase. We found that using our designed GDPs (Talaat et al., [@B59]) yielded a better representation of the transcriptomes than using the standard random primers (see Table [1](#T1){ref-type="table"} for detailed results). Clearly, RNA-Seq provided a higher-resolution analysis of *M. tuberculosis* transcription that cannot be matched by our earlier analysis using DNA microarrays (Talaat et al., [@B58]).

###### 

**Results from RNA-Seq of *M. tuberculosis* grown in vitro using random primers vs. genome-directed primers (GDPs)**.

                                                                     Random primers[\*\*](#tfn2){ref-type="table-fn"}   GDPs[\*\*](#tfn2){ref-type="table-fn"}
  ------------------------------------------------------------------ -------------------------------------------------- ----------------------------------------
  Material submitted                                                 1 μg RNA                                           1.5 μg cDNA
  Total reads[\*](#tfn1){ref-type="table-fn"}                        3,408,529                                          4,656,852
  Total reads mapped                                                 2,855,091                                          4,147,021
  Reads mapped to rRNA or tRNA[\*\*\*](#tfn3){ref-type="table-fn"}   2,174,262                                          2,324,778
  Unique coding sequence reads                                       672,632                                            1,807,890
  Non-specific coding sequence reads                                 8,197                                              14,353
  Reads not mapped                                                   553,438                                            509,831
  Most sequenced RNA (reads)                                         *rrl* (1,442,762)                                  *rrl* (1,388,167)
  Most sequenced mRNA (reads)                                        *PPE60* (5,168)                                    *rv1398c* (12,623)
  Transcripts not detected                                           44                                                 34

*Sequencing was performed on Illumina Solexa Genome Analyzer II platform at the UW Biotechnology Center*.

*\*Read length was 75 bp*.

*\*\*R-value for reads using random primers vs. reads using GDPs was 0.913 (R^2^ = 0.834)*.

*\*\*\*For both experiments, rRNA reduction was performed using MICROBExpress (Ambion) prior to amplification into cDNA with either random primers or GDPs*.

Tuberculosis Models of Infection
================================

To gain insights into the molecular pathogenesis of *M. tuberculosis*, many transcriptional profiling studies have been conducted within various models of tuberculosis infection. We will highlight the major tuberculosis models of infection suitable for transcriptional profiling techniques before delving into what we have learned from the generated *M. tuberculosis* transcriptomes. To begin, *in vitro* models have been developed that incorporate exposure of *M. tuberculosis* growing in culture to conditions thought to be similar to those experienced within the host microenvironment. For example, studies have been conducted under exposure to acid, oxidative stress, and nutrient starvation (Betts et al., [@B5]; Fisher et al., [@B17]; Schnappinger et al., [@B49]). One of the most well-established *in vitro* models for *M. tuberculosis* is the Wayne model, which uses oxygen deprivation to mimic the conditions found in a tuberculosis granuloma (Wayne and Hayes, [@B68]; Wayne and Sohaskey, [@B69]). In another recently developed *in vitro* multiple stress model, *M. tuberculosis* bacilli are subjected to multiple stresses including low oxygen, high CO~2~, low nutrient availability, and acidic pH (Deb et al., [@B16]). These models have been useful in identifying and characterizing the genes within the *M. tuberculosis* genome.

A prime example of *in vitro* microarray studies includes those that identified the DosR regulon, a group of genes responsible for transitioning *M. tuberculosis* from an aerobic state to an anaerobic, persistent state (Park et al., [@B40]; Converse et al., [@B12]). However, although a knockout mutant of *dosR* caused attenuation within the mouse model, it was still able to establish a persistent infection (Converse et al., [@B12]). In addition to the inability of *in vitro* models to fully mimic the fluctuation and feedback found in an *in vivo* system, creating accurate *in vitro* models is also a difficult task because the conditions found in a mycobacterial phagosome are still not entirely known. Therefore, despite the utility of *in vitro* host models, particularly those that incorporate multiple stresses, they are unlikely to accurately represent the normal surroundings of intracellular pathogens such as *M. tuberculosis*. We are convinced that using *in vivo* models of infection will more closely represent the complex environment found in human lungs and provide a wealth of information related to *M. tuberculosis* pathogenesis.

Because *M. tuberculosis* is an intracellular pathogen, *ex vivo* macrophage infections can provide a model similar to its natural environment. Cell culture infections have been used to study host response to infection (Danelishvili et al., [@B15]; Xu et al., [@B71]; McGarvey et al., [@B36]), and several large-scale studies profiling the mycobacterial transcriptome have been done. Infected THP-1 cells, which are cultured human monocytes, have been used to stimulate a host environment (Fontán et al., [@B19]). Additionally, primary cultures of murine macrophages as well as human macrophages have been used for microarray analysis (Schnappinger et al., [@B49]; Cappelli et al., [@B9]; Rachman et al., [@B43]; Tailleux et al., [@B57]). Although macrophages are more similar to the natural host environment than an *in vitro* system, the absence of interacting immune cells such as T cell, natural killer cells, and dendritic cells, and the lack of a granulomatous structure, are disadvantages to cell culture systems.

While humans represent the only natural reservoir for *M. tuberculosis*, many standard laboratory animals are capable of being infected with human strains via aerosolization, which most closely mimics natural infection. Mice represent the most commonly used animal model for tuberculosis, and the murine model provides a relatively tractable system in which to study *M. tuberculosis* pathogenesis. However, difficulty in isolating sufficient amounts of mycobacterial transcripts from host tissue mean that only a few large-scale transcriptional profiles within this model have been completed (Talaat et al., [@B60], [@B61]). Additionally, the murine model is not able to completely replicate the biology of human tuberculosis. Although mice develop granulomas, they are not as defined and organized as the granulomas observed in humans, or even other animal models such as guinea pigs. Also, mice carry a high bacterial load and display progressively deteriorating lung pathology during chronic infection, whereas the latent stage in humans is asymptomatic and characterized by low bacterial numbers (Flynn, [@B18]). Other less-common animal models include the use of guinea pigs, rabbits, and non-human primates for infections (Gupta and Katoch, [@B23]; Flynn, [@B18]). Financial restrictions and host-specific technical challenges mandates that large-scale transcriptional profiling has yet to be done within these models, although qRT-PCR has been used to profile select gene expression within infected rabbit lung tissue (Kesavan et al., [@B31]) as well as primate tissue ([tbdb.org](tbdb.org)).

Finally, an additional option to obtain *in vivo* profiling data of pathogens is to isolate bacterial RNA directly from infected patients. In the case of *M. tuberculosis*, this requires access to sections of infected lung tissue, a limitation that has made profiling within human tissue rare. However, a few instances of transcriptional profiling within human lungs have been reported (Timm et al., [@B62]; Rachman et al., [@B44]). These studies can be considered the most accurate representation of genes expressed by *M. tuberculosis* during human infection. However, in addition to the difficulty in obtaining samples, other downsides to profiling within humans include the potential effect of chemotherapy treatment on bacterial transcription, the potential introduction of artifacts during sample transport and storage, and the inability to reproduce experiments due to diverse genetic backgrounds. In the next sections, we will focus our attention on specific examples where large-scale analyses were useful in delineating novel aspects of tuberculosis pathogenesis.

Genes Expressed inside Macrophages
==================================

The murine macrophage model
---------------------------

A few whole-genome transcriptional profiles of *M. tuberculosis* growing within murine primary cell culture have been conducted using murine bone-marrow derived macrophages. Rachman et al. ([@B43]) used microarrays to profile the transcriptomes of *M. tuberculosis* within both active and resting macrophages relative to *in vitro* culture. Approximately 190 genes were identified as upregulated in response to the resting macrophage vs. liquid bacterial culture *in vitro*, or the activated macrophage vs. resting macrophage state. The upregulation of siderophore-encoding genes *mbtJ* and *mbtI* indicated that the bacteria were responding to iron limitation. Genes associated with amino acid synthesis and lipid metabolism were also upregulated, suggesting nutrient deprivation and the switch to lipids as a carbon source. Genes encoding cell wall components, stress response mechanisms, and regulatory proteins were also identified as induced within murine macrophages.

Similarly, Schnappinger et al. ([@B49]) identified over 400 genes that were induced after phagocytosis by either resting or active murine macrophages relative to bacteria grown in culture. Despite the use of the same *ex vivo* model, only 27 genes were identified in both the Rachman and Schnappinger study (Figure [1](#F1){ref-type="fig"}A), possibly reflecting the differences in experimental conditions such as time points and bacterial load. Interestingly, despite the low number of overlap in genes identified in both studies, the functional categories identified were very similar. As with the Rachman study, the Schnappinger study found groups of genes associated with iron scavenging, the cell wall, and lipid metabolism. In addition, the Schnappinger study identified genes associated with anaerobic respiration and dormancy, such as *narX* and *ndh*, indicating that a switch to anaerobic respiration may occur in cell culture models, and particularly in macrophages that have been activated with IFN-γ. Curiously, the largest functional category within the overlap between the two studies was a high number of predicted transposases (6/27). Although the role for transposases within host infection is unknown, their upregulation is associated with DNA damage (Boshoff et al., [@B6]).

![**Meta-analysis of *M. tuberculosis* transcriptomes using variable models of infection**. **(A)** Macrophage expression data following infection with *M. tuberculosis* reveals overlap of upregulated genes identified in three macrophage models of *M. tuberculosis* infection (Schnappinger et al., [@B49]; Rachman et al., [@B43]; Fontán et al., [@B19]). **(B)** Expression data in three models of tuberculosis infection, including *ex vivo* macrophage infection, mouse infection, and profiling of infected human lung tissue (Schnappinger et al., [@B49]; Talaat et al., [@B60]; Rachman et al., [@B43],[@B44]; Fontán et al., [@B19]).](fmicb-01-00121-g001){#F1}

The human macrophage model
--------------------------

Microarray analysis performed by Fontán et al. ([@B19]) examined macrophage infection using THP-1 cells, a human-derived cultured cell line. Approximately 380 genes were identified as upregulated intracellularly relative to *M. tuberculosis* grown in broth culture. Unlike the primary mouse macrophages, *M. tuberculosis* living within cultured human macrophages did not reveal upregulation of iron uptake genes. In fact, upregulation of *bfrA*, a gene associated with high levels of iron availability, occurred within this model. However, the THP-1 model identified other groups similar to those found in the murine macrophage studies, such as signs of lipid metabolism and cell envelope stress. This study also revealed the upregulation of many transcriptional regulators, including *whiB3*, *ideR*, *mprA*, and *dosR*. The THP-1 study had only 15 genes in common with the Rachman study, most of which encode uncharacterized hypothetical proteins. On the other hand, it had a 71-gene overlap with the Schnappinger study, including many transcriptional regulators, membrane proteins, and lipid synthesis enzymes.

Additional microarray studies within human macrophages have used primary cultured macrophages isolated from healthy humans (Cappelli et al., [@B9]; Tailleux et al., [@B57]). Cappelli et al. ([@B9]) discovered that genes associated with the cell wall, oxidative damage repair, and regulatory functions were upregulated, while iron-associated genes were not. The identification of the upregulated sigma factor *sigG* in this study was unique to the primary culture human model, and SigG was confirmed to be required for full survival within macrophages (Lee et al., [@B33]). Tailleux et al. ([@B57]) studied the transcriptional response of *M. tuberculosis* within human-derived macrophages as well as dendritic cells. The induction of genes associated with anaerobic respiration, including *narX*, was observed, as well as the induction of genes associated with lipid metabolism. Interestingly, this study concluded that dendritic cells represent a more nutrient-limited environment for *M. tuberculosis* than macrophages, as evidenced by the increased upregulation of genes associated with amino acid synthesis and cholesterol metabolism.

Overlap in macrophage-induced genes
-----------------------------------

Comparing the transcriptional data from the two murine cell infections with the human THP-1 infection revealed only four genes that were identified as significantly upregulated in all three analyses, most likely due to differences in experimental setup (Schnappinger et al., [@B49]; Rachman et al., [@B43]; Fontán et al., [@B19]). Two of these genes (*rv1057*, *rv2012*) are completely uncharacterized, and one is a putative methyltransferase (*rv1405c*) of unknown biological function that was identified as necessary for infection within a mouse model (Sassetti and Rubin, [@B48]). The only functionally characterized gene identified in all three studies was isocitrate lyase (*icl1*), which is known to be involved in the utilization of fatty acids within the host (Höner Zu Bentrup et al., [@B29]). When *icl1* was knocked out and the mutant tested in a murine model, studies revealed attenuation in both persistence and virulence (McKinney et al., [@B37]; Muñoz-Elías and McKinney, [@B39]). Overall, the macrophage studies have sketched the macrophage as a location where *M. tuberculosis* responds to oxidative stress, utilizes lipids as a carbon source, and modulates cell wall components. Other areas, such as iron availability, seem to provide different pictures depending on the cell culture model used. The high number of uncharacterized genes that are identified consistently among all macrophage studies emphasizes the need for continued basic research on characterizing the genome of *M. tuberculosis*.

Genes Expressed During Murine Infection
=======================================

In 2004, our group published an *in vivo* microarray analysis study of immune-competent and immune-deficient mice infected with *M. tuberculosis* (Talaat et al., [@B60]). Whole-genome expression levels were measured weekly over the course of the first 4 weeks of infection. One of the major findings of this study was a region of 32 consecutive genes that was highly expressed in the mouse lung tissue relative to its expression levels when grown outside the host, in liquid culture media. This region of the genome was termed the iVEGI, for *in vivo* expressed genomic island (Figure [2](#F2){ref-type="fig"}A). Since that publication, further characterization of all of the operons within the iVEGI has been an area of active research both in our laboratory and others. We have come to understand more about the functions performed by the gene products encoded in the iVEGI, some of which were previously associated with *in vivo* survival, such as lipid synthesis, while others represented new insights into environmental stress, such as copper toxicity and novel protease/chaperone activity. Importantly, we have also shown that most of the operons within the iVEGI are required for full virulence within animal host models.

![**Analysis of key *M. tuberculosis* expressed genes in mice**. **(A)** Schematic of the genetic organization of the *in vivo* expressed genomic island (iVEGI). Genes that have been targeted for deletion and tested for virulence within animal model(s) are bolded. **(B)** Murine survival curves after infection with the wild-type strain (H37Rv), or with targeted deletion strains created based on *in vivo* transcriptional profiling. Mouse groups were infected using aerosol infection (Glas-col inhalation system) using 100--300 CFU/animal (Abomoelak et al., [@B1]). The survival of infected mice was monitored over the course of a 1-year infection.](fmicb-01-00121-g002){#F2}

The first operon in the iVEGI, termed *cso* (*c*opper *s*ensitive *o*peron), encodes four genes: *csoR*, *rv0968*, *ctpV*, and *rv0970*. The first gene, *csoR*, has been shown to encode a transcriptional regulator that binds or releases DNA in response to the intracellular level of copper (Liu et al., [@B34]). At least one of the genes controlled by CsoR, *ctpV*, is directly involved in reducing the effects of copper toxicity. CtpV is proposed to function as a copper exporter based on sequence analysis and experimental data (Ward et al., [@B66]). Recent research suggests that copper toxicity may represent a source of host-mediated *in vivo* stress that successful pathogens must overcome through carefully regulated copper response mechanisms, such as those represented by CsoR and CtpV (Percival, [@B41]; Wagner et al., [@B64]; Ward et al., [@B66]).

A knockout mutant of the entire *cso* operon was created, Δ*cso*, and was tested in a mouse model. Results showed an approximately 1.5-log reduction in the colonization levels of Δ*cso* relative to H37Rv, the virulent wild-type strain, at 38 weeks post-infection (Abomoelak et al., [@B1]). Additionally, a single-gene knockout of CtpV was created, Δ*ctpV*. This knockout mutant was tested in both a mouse model and a guinea pig model of infection (Ward et al., [@B66]). The same phenotype was seen in both host models: although survival of Δ*ctpV* was similar to the wild-type strain H37Rv along the course of infection, damage to host tissue was lessened by the deletion of the *ctpV* gene, and mice infected with Δ*ctpV* survived longer relative to those infected with H37Rv (Figure [2](#F2){ref-type="fig"}B). This reduction in pathology and mortality shows that *ctpV* is required for full virulence of *M. tuberculosis*, despite not being required for survival within a host.

Operon 2 of the iVEGI encodes six genes predicted to be involved in lipid metabolism. The genes encode a putative enoyl-CoA hydratase thought to be involved in the oxidation of fatty acids (*echA7*), two predicted acyl-coA dehydrogenases (*fadE12*, *fadE13*), two genes involved in the synthesis of mycolic acids (*accA2*, *accD2*), as well as one uncharacterized gene (*rv0976c*). Overall, the operon is likely involved in fatty acid metabolism and anabolism, processes key to *M. tuberculosis* pathogenesis, including formation of the unique cell wall as well the utilization of fatty acids as a carbon source. The genes involved in synthesizing and breaking down fatty acids are extremely prevalent within the *M. tuberculosis* genome, making it likely that some or all of the genes in Operon 2 are redundant (Kinsella et al., [@B32]). A non-polar knockout of the first gene in Operon 2, *echA7*, was created in our laboratory using a specialized transduction system (Bardarov et al., [@B3]) and used to infect mice (Figure [2](#F2){ref-type="fig"}B). Despite its probable functional redundancy, Δ*echA7* showed attenuation in an aerosol mouse model of infection, with the Δ*echA7* mutant colonizing with approximately one log fewer bacteria relative to H37Rv over the course of infection at both short-term (4 weeks) and long-term (up to 38 weeks) time points (data not shown). The Δ*echA7* mutant also displayed extremely reduced virulence, with the infected mice surviving for the entire duration of the mouse survival experiment (1 year) compared to the average time-to-death of mice infected with H37Rv (31 weeks) (Figure [2](#F2){ref-type="fig"}B).

The third operon of the iVEGI encodes a two-component regulatory system (MprAB; He and Zahrt, [@B26]), as well as a protease (PepD) (Mohamedmohaideen et al., [@B38]; White et al., [@B70]) and an uncharacterized gene thought to be involved in molybdopterin synthesis (*moaB2*). The MprAB system consists of a response regulator (MprA) and a sensor kinase (MprB). This system has been shown to regulate many genes, including the genes encoding sigma factors SigB and SigE, in response to cellular stresses and particularly membrane stress (He et al., [@B25]). An Δ*mprAB* deletion mutant failed to establish a persistent infection in mice, suggesting that it could be required for the entrance into chronic tuberculosis (Zahrt and Deretic, [@B72]). PepD is proposed to function as a protease and chaperone involved in mycobacterial stress response and is under the control of MprAB (Skeiky et al., [@B53]; Mohamedmohaideen et al., [@B38]; White et al., [@B70]). Similar to the Δ*ctpV* mutant, a Δ*pepD* mutant did not have a colonization defect within a mouse model, but animals infected with the mutant displayed less lung tissue damage relative to those infected with H37Rv, and mutant-infected mice lived longer than those infected with H37Rv (Mohamedmohaideen et al., [@B38]).

Operon 4 of the iVEGI encodes three genes: *rv0986*, *rv0987*, and *rv0988*, which together encode components of an ABC transporter (Braibant et al., [@B8]). Functional characterization of an Δ*rv0986* knockout mutant revealed that this transporter is required for invasion of host cells as well as the blocking of phagosome--lysosome fusion within the host macrophage cell (Pethe et al., [@B42]; Rosas-Magallanes et al., [@B46]). Testing of a knockout mutant within this operon occurred within a murine model for central nervous system tuberculosis, with a knockout mutant of *rv0986* less able to invade brain tissue (Be et al., [@B4]). Operon 4 is thus far the only operon shown to be horizontally transferred within the iVEGI. The operon as a whole is specific to the *M. tuberculosis* complex and has an unusually low GC content as well as distinct codon usage from the rest of the genome (Rosas-Magallanes et al., [@B46]). Overall, analysis conducted so far indicates the involvement of the iVEGI in *M. tuberculosis* pathogenesis and virulence.

In a second microarray study using the murine model that focused on the chronic stage of tuberculosis, mycobacterial RNA were successfully extracted from infected mouse lungs at 28, 45, and 60 days post-infection (Talaat et al., [@B61]). Surprisingly, these microarrays revealed that *M. tuberculosis* bacilli remain metabolically active during chronic tuberculosis, even though bacterial counts remain the same. Pathways for carbohydrate metabolism, lipid metabolism, and energy metabolism were significantly upregulated. These analyses identified several clustered sets of genes, including a group of 12 *in vivo* expressed genes upregulated at all three time points relative to *in vitro* cultures. Included in this group was *mprA* of the iVEGI island as well as a previously uncharacterized gene, *mosR*, which was the most highly expressed gene of the cluster, at 200-fold upregulated. Further investigation of the role of MosR revealed that a Δ*mosR* strain is attenuated in a murine model of tuberculosis, and affects the expression of operons involved in mycobacterial survival at late stages of infection, likely through transcriptional regulation (Abomoelak et al., [@B1]).

Profiling of Human Infection
============================

A disadvantage of the *in vivo* models reviewed thus far is that, while host models can provide a closer insight into human pathogenesis than *in vitro* models, they are still unable to wholly replicate the natural, human environment of *M. tuberculosis*. A study of *M. tuberculosis* transcription within resected human lung tissue was conducted using qRT-PCR, with results compared to expression levels found in the murine model (Timm et al., [@B62]). Interestingly, this study found that genes associated with iron limitation were not as induced in human lung as they were in mouse lung, which together with the cell culture data presented earlier, suggests that metal availability within the phagosome could be species-specific. Expression levels of *icl1*, found to be highly expressed in the macrophage model and necessary for pathogenesis in the murine model, showed that *icl1* levels vary depending on the lung specimen used, possibly due to differences in oxygen availability between different types of granulomatous tissue.

A second study used microarray analysis to profile the expression of *M. tuberculosis* in resected lung tissue removed from patients with severe tuberculosis, often caused by multiple drug resistant (MDR) strains (Rachman et al., [@B44]). The profiling study revealed upregulation of genes involved in the modification of the cell wall, including fatty and mycolic acids. Included in this group of cell wall-associated genes were many PE and PPE family genes, a family of surface proteins specific to mycobacteria whose function is not yet completely understood (Bottai and Brosch, [@B7]). Genes for protein chaperones and detoxification activities were also identified, as was seen in the murine model, as well as genes associated with transposition and insertion elements, as had been identified in the macrophage models. Finally, genes involved in both aerobic and anaerobic respiration were seen, and the transcriptional profiles of these genes differed depending on the site of the tissue being studied (e.g., granuloma vs. distant lung tissue), supporting the idea that both aerobic and anaerobic models may be used to represent different sites of human infection.

Although the overall categories of genes identified in the human study were similar to those seen within mouse models of infection, the specific genes identified had little overlap with those found in the model. For example, a comparison of genes upregulated in the human granuloma vs. genes upregulated in chronically infected mice revealed only four genes in common between the two data sets: *PPE61*, *PPE55*, *rv0316*, predicted to be involved in cholesterol utilization, and *rv3706c*, of unknown function. Between all genes upregulated in the murine and THP-1 macrophage models (860 genes total) and the genes upregulated in the human granuloma (187 genes), only 42 genes overlapped (Table [2](#T2){ref-type="table"}). This 42 gene overlap includes *PPE61*, *PPE55*, and *rv3706* also found in the mouse model (Figure [1](#F1){ref-type="fig"}B; Table [2](#T2){ref-type="table"}). Notably, PPE55 has also been identified as a potential vaccine target based on its antigenicity (Singh et al., [@B52]; Zvi et al., [@B73]). However, as has been seen in other models, the largest category of genes identified in the human study was uncharacterized, hypothetical proteins.

###### 

**The overlap in genes identified in multiple *in vivo* models, as represented in Figure [1](#F1){ref-type="fig"}B**.

                                       Intersection of cell culture and human granuloma data[\*](#tfn4){ref-type="table-fn"}                                                                                               Intersection of cell culture and murine lung data[\*\*](#tfn5){ref-type="table-fn"}
  ------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------
  DNA modification                     None                                                                                                                                                                                *rv1199c, rv2659c*, *rv3115*, *rv3023c*
  Energy and intermediate metabolism   *cyp141*, *fprB*, *gltA2*, *ppa*, *rocA*, *rv0083*, *rv2962c*                                                                                                                       None
  Lipid metabolism                     *desA1*, *fadE30*, *fadD3*, *rv3229c*                                                                                                                                               *nrp*, *papA2*
  Membrane-associated                  *betP*, *lppZ*, *PE11*, *PE34*, *PPE55*, *PPE61*, *rv0797*, *rv2090*, *rv3636*                                                                                                      *PPE55*, *PPE61*, *rv0188*
  Protein synthesis and repair         *asnB*, *clpP2*, *hsp*, *pyrG*                                                                                                                                                      *mshB*
  Regulatory proteins                  *rv2642*                                                                                                                                                                            *mprA*, *rv0324*
  Uncharacterized                      *rv0293c*, *rv0361*, *rv1738*, *rv1896c*, *rv1952*, *rv2005c*, *rv2160c*, *rv2262c*, *rv2557*, *rv2603c*, *rv3412*, *rv3555c*, *rv3626c*, *rv3706c*, *rv3776*, *rv3860*, *rv3861*   *rv0150c*, *rv1190*, *rv1291c*, *rv1518*, *rv1587c*, *rv1734c*, *rv1945*, *rv3706c*, *rv3845*

*\*Genes were identified as upregulated within cell culture experiments (Schnappinger et al., [@B49]; Rachman et al., [@B43]; Fontán et al., [@B19]) and human lung granulomas (Rachman et al., [@B44])*.

*\*\*Genes were identified as upregulated within cell culture experiments (Schnappinger et al., [@B49]; Rachman et al., [@B43]; Fontán et al., [@B19]) and murine lung tissue (Talaat et al., [@B60])*.

Concluding Remarks
==================

*In vivo* studies have been very useful as a tool to better understand the host environment that *M. tuberculosis* experiences during human infection. Studies of macrophages, animal models, and even human lungs have all helped researchers make inferences about the host environment based on the reaction of *M. tuberculosis* to its surroundings. However, as tuberculosis continues to pose a looming threat to global health, it is important to mine through this expression data to infer clues not only about the host status but also about the factors enabling the virulence and pathogenesis of the bacteria. Studies conducted so far of strains containing mutations in genes identified through *in vivo* profiling suggest that this could be an effective way to identify gene products important to the bacteria. These genes could serve as interesting targets for applications such as vaccine creation and anti-mycobacterial drug targeting. Serving to complicate this process, the environment of *M. tuberculosis* is difficult to duplicate. Even within human host tissue itself, gene expression differs based on the biological variation seen not only from patient to patient, but even within different locations of the granuloma itself.

Despite these challenges, comparisons of the available data allows for the discovery of genes that are expressed highly in multiple models and across different locations and time points, which can help distinguish biological phenomena from experimental artifacts. Because no one model can accurately represent the full course of human disease, this type of meta-analysis may be the best way to obtain meaningful data from *in vivo* models. Therefore, it is important to keep in mind that if whole-genome data is to be utilized efficiently by the research community, it must be fully disseminated using standardized terminology, and in fact, the online database [tbdb.org](tbdb.org) has recently been created for this reason (Galagan et al., [@B21]). It is equally imperative to prepare ourselves for the types of data that will emerge from new techniques, including advances in proteomics (Rao and Li, [@B45]) and metabolomics, which will allow future studies to account for post-transcriptional disease regulation, as well as next-generation sequencing, which represents an important new direction for transcriptional profiling studies.
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